News

Filter

Current filters:

Solaris

Orphan status for Alexion's Solaris

16-07-2013

US drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) says that Soliris (eculizumab), the company's first-in-class…

Alexion PharmaceuticalsBiotechnologyEuropeNeurologicalPharmaceuticalRare diseasesRegulationSolaris

New Zealand declines Alexion's funding application for Solaris

21-05-2013

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to decline the…

Alexion PharmaceuticalsAsia-PacificHealthcarePharmaceuticalPricingRare diseasesSolaris

COMPANY SPOTLIGHT

Menarini

Back to top